hydromorphone
hydromorphone structure
|
Common Name | hydromorphone | ||
|---|---|---|---|---|
| CAS Number | 466-99-9 | Molecular Weight | 285.338 | |
| Density | 1.4±0.1 g/cm3 | Boiling Point | 475.6±45.0 °C at 760 mmHg | |
| Molecular Formula | C17H19NO3 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | 241.4±28.7 °C | |
| Symbol |
GHS02, GHS06, GHS08 |
Signal Word | Danger | |
|
The slow death of lethal injection.
BMJ 348 , g2670, (2014)
|
|
|
Canada in breach of ethical standards for clinical trials.
CMAJ 186(1) , 11, (2014)
|
|
|
What is your gut feeling about opioid rotation?
J. Clin. Oncol. 33(3) , e11-2, (2015)
|
|
|
Comparative pathophysiology, toxicology, and human cancer risk assessment of pharmaceutical-induced hibernoma
Toxicol. Appl. Pharmacol. 273(3) , 456-63, (2013) In humans, hibernoma is a very rare, benign neoplasm of brown adipose tissue (BAT) that typically occurs at subcutaneous locations and is successfully treated by surgical excision. No single cause has been accepted to explain these very rare human tumors. In ... |
|
|
Influence of intensive care treatment on the protein binding of sufentanil and hydromorphone during pain therapy in postoperative cardiac surgery patients.
Br. J. Anaesth. 113(4) , 677-87, (2014) Our objective was to evaluate the effect of intensive care treatment on the protein binding of sufentanil and hydromorphone in cardiac surgery patients during postoperative analgesia using a target-controlled infusion (TCI) and patient-controlled analgesia (P... |
|
|
Effective analgesia with low-dose ketamine and reduced dose hydromorphone in ED patients with severe pain.
Am. J. Emerg. Med. 31(5) , 847-51, (2013) We assessed the analgesic effect and feasibility of low-dose ketamine combined with a reduced dose of hydromorphone for emergency department (ED) patients with severe pain.This was a prospective observational study of adult patients with severe pain at an urb... |
|
|
Dexmedetomidine and hydromorphone: a novel pain management strategy for the oncology ward setting during anti-GD2 immunotherapy for high-risk neuroblastoma in children.
Pediatr. Blood Cancer 62(1) , 29-34, (2015) Treatment of neuroblastoma with targeted immunotherapy using chimeric anti-GD2 monoclonal antibodies (ch14.18) is associated with significant pain requiring management with a high-dose opioid infusion. We present a case series of six children, for whom dexmed... |
|
|
Antinociceptive efficacy of buprenorphine and hydromorphone in red-eared slider turtles (Trachemys scripta elegans).
J. Zoo Wildl. Med. 43(3) , 662-5, (2012) Despite the frequent clinical use of buprenorphine in reptiles, its antinociceptive efficacy is not known. In a randomized, complete cross-over study, the antinociceptive efficacy of buprenorphine (0.2 mg/kg s.c.) was compared with hydromorphone (0.5 mg/kg s.... |
|
|
Evaluation of topical epidural analgesia delivered in gelfoam for postoperative hemilaminectomy pain control.
Vet. Surg. 42(1) , 79-84, (2013) To evaluate efficacy of a topical epidural analgesia used alone, or in combination with hydromorphone, against a standard pain protocol for the 48 hours immediately after hemilaminectomy.Randomized, blinded, controlled, clinical trial.Dogs (n = 30) with thora... |
|
|
Postoperative global amnesia reversed with flumazenil.
Neurologist 18(4) , 216-8, (2012) Global postoperative amnesia (profound anterograde and retrograde amnesia) is rare and usually attributed to transient global amnesia-a poorly understood condition with no broadly accepted mechanism. We report an incident of probable transient global amnesia ... |